Literature DB >> 31705888

SNAP-25 Contributes to Neuropathic Pain by Regulation of VGLuT2 Expression in Rats.

Jian Wang1, Wei Xu2, Yan Kong1, Jiangju Huang1, Zhuofeng Ding1, Meiling Deng1, Qulian Guo3, Wangyuan Zou4.   

Abstract

Synaptosomal-associated protein 25 (SNAP-25) plays an important role in neuropathic pain. However, the underlying mechanism is largely unknown. Vesicular glutamate transporter 2 (VGluT2) is an isoform of vesicular glutamate transporters that controls the storage and release of glutamate. In the present study, we found the expression levels of VGluT2 correlated with the upregulation of SNAP-25 in the spinal cord of rats following chronic constriction injury (CCI)-induced neuropathic pain. Cleavage of SNAP-25 by Botulinum toxin A (BoNT/A) attenuated mechanical allodynia, downregulated the expression of VGluT2 and reduced glutamate release. Overexpression of VGluT2 abolished the antinociceptive effect of BoNT/A. Upregulation of SNAP-25 in naive rats increased VGluT2 expression and induced pain-responsive behaviors. In pheochromocytoma (PC12) cells, the expression of VGluT2 was also depended on SNAP-25 dysregulation. Moreover, we found VGluT2 was involved in SNAP-25-mediated regulation of astrocyte expression and activation of the PKA/p-CREB pathway mediated the upregulation of SNAP-25 in neuropathic pain. The findings of our study indicate that VGluT2 contributes to the effect of SNAP-25 in maintaining the development of neuropathic pain and suggests a novel mechanism underlying SNAP-25 regulation of neuropathic pain.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PKA; SNAP-25; VGluT2; neuropathic pain

Year:  2019        PMID: 31705888     DOI: 10.1016/j.neuroscience.2019.10.007

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Synaptic Cell Adhesion Molecule 3 (SynCAM3) Deletion Promotes Recovery from Spinal Cord Injury by Limiting Glial Scar Formation.

Authors:  Byeong Gwan Song; Su Yeon Kwon; Jae Won Kyung; Eun Ji Roh; Hyemin Choi; Chang Su Lim; Seong Bae An; Seil Sohn; Inbo Han
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 2.  A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury.

Authors:  Celine Lakra; Helen Cohen
Journal:  J Spinal Cord Med       Date:  2020-12-02       Impact factor: 2.040

3.  PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model.

Authors:  Xilei Li; Qulian Guo; Zhi Ye; E Wang; Wangyuan Zou; Zhihua Sun; Zhenghua He; Tao Zhong; Yingqi Weng; Yundan Pan
Journal:  Front Neurosci       Date:  2021-03-24       Impact factor: 4.677

4.  A Bioinformatics Study of Differentially Expressed Genes in Microarrays of Dorsal Root Ganglia from Rat Models of Neuropathic Pain.

Authors:  Yongle Wu; Hai Nie
Journal:  Med Sci Monit       Date:  2022-02-15

5.  Dysregulation of Vesicular Glutamate Transporter VGluT2 via BDNF/TrkB Pathway Contributes to Morphine Tolerance in Mice.

Authors:  Liqiong He; Wei Xu; Chengliang Zhang; Zhuofeng Ding; Qulian Guo; Wangyuan Zou; Jian Wang
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.